// App-Quantinova.ai

S128 : STANDARDIZING NGS-MRD IN AML: AN INTERNATIONAL STUDY BY THE ELN-MRD WORKING PARTY

Researchers

Presenter

  • Michael Heuser

Principal Investigators

  • Yasmine Alwie

  • Constance Regina Baer

  • Louisa-Kristin Dallmann

  • Laura Dillon

  • Richard Dillon

  • Konstanze Doehner

  • Nicolas Duployez

  • Linda Fogelstrand

  • Christina Ganster

  • Detlef Haase

  • Torsten Haferlach

  • Luise Hartmann

  • Julia Herzig

  • Kinga Hincza

  • Christopher S. Hourigan

  • Piroska Klement

  • Artur Kowalik

  • Marta Libura

  • Klaus H. Metzeler

  • Marlen Metzner

  • Rachel Moore

  • Claude Preudhomme

  • Bert van der Reijden

  • Katrin Teich

  • Christian Thiede

  • Peter J.M. Valk

  • Paresh Vyas

  • Bartosz Wasag

  • Martin Wichmann

  • Clara Philine Wienecke

  • Arnold Ganser

  • Felicitas Thol

Medical Centers

  • Department of Hematology and Oncology, University Medical Center, Freiburg, Germany

  • Laboratory for Leukemia Diagnostics, Dept. of Internal Medicine III, University Hospital Grohadern, Ludwig-Maximilians-Universitat, Munich, Germany

  • Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Gelderland, Netherlands

  • Department of Internal Medicine, University Hospital of Ulm, Ulm, Germany

  • Department of Molecular Diagnostics, Holycross Cancer Center, Kielce, Poland

  • Division of Medical Biology,Institute of Biology Jan Kochanowski University,Kielce,Poland

  • Department of Haematology, Oncology and Internal Diseases,Medical University and University Hospital,Warsaw,Poland

  • Department of Clinical Genetics, Sahlgrenska University Hospital, Gothenburg, Sweden

  • Cancer Genetics Laboratory, Department of Medical and Molecular Genetics,King's College,London,United Kingdom

  • Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden

  • Department of Clinical Genetics, Sahlgrenska University Hospital, Gothenburg, Sweden

  • Dept. Hematology, Hemostaseology, Oncology & Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

  • Medical Department I,University Hospital and Faculty of Medicine, TU Dresden,Dresden,Germany

  • Laboratory of Chronic Airway Infection, The National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States,

  • Munich Leukemia Laboratory, Munich, Germany.

  • Laboratory of hematology,CHRU de Lille,Lille,France

  • Laboratory of hematology,CHRU de Lille,Lille,France

  • Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands

  • Department of Biology and Medical Genetics,Medical University of Gdansk,Gdansk,Poland

  • MRC Molecular Haematology Unit, BRC Haematology Theme,Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital,Oxford,United Kingdom

Locations

  • Germany

  • Netherlands

  • Poland

  • Sweden

  • United Kingdom

  • United States

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Nucleophosmin 1

  • KIT Proto-Oncogene, Receptor Tyrosine Kinase

  • Isocitrate dehydrogenase 1

  • Isocitrate dehydrogenase 2

  • Tumor protein p53

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved